Skip to main content
Ondine Biomedical Inc. logo

Ondine Biomedical Inc. — Investor Relations & Filings

Ticker · OBI ISIN · CA68234M2058 LEI · 9845005B69E07CGF4A56 TSXV Manufacturing
Open in API
Filings indexed 223 across all filing types
Latest filing 2023-10-23 Regulatory Filings
Country CA Canada
Listing TSXV OBI

About Ondine Biomedical Inc.

https://ondinebio.com/

Ondine Biomedical Inc. is a life sciences company that develops and commercializes photodisinfection-based therapies to prevent and treat a broad spectrum of infections, including those caused by drug-resistant pathogens. The company's patented platform technology involves applying a photosensitive agent to a targeted area, followed by illumination with non-thermal laser light. This process creates an oxidative burst that rapidly destroys pathogens like bacteria, viruses, and fungi without inducing microbial resistance. Its lead product, Steriwave™, is a nasal decolonization therapy used to eradicate pathogens in the nasal cavity, primarily to reduce the risk of healthcare-associated infections (HAIs) such as post-operative surgical site infections. The company's product pipeline is exploring applications for chronic rhinosinusitis, burns, wounds, and ventilator-associated pneumonia.

Recent filings

Filing Released Lang Actions
66.5% reduction in spine surgery infection rate
Regulatory Filings Classification · 95% confidence The document is a press release distributed via the RNS Reach service. It details clinical research findings regarding the company's product, Steriwave, and its impact on infection rates at a hospital. It does not constitute a formal financial report, regulatory filing, or governance document, but rather a corporate announcement of research results. As it is a general corporate announcement that does not fit into specific categories like 10-K or IR, it is classified as a Regulatory Filing (RNS).
2023-10-23 English
Steriwave shown to reduce resistant bacteria
Regulatory Filings Classification · 98% confidence The document is a press release distributed via the London Stock Exchange's 'Reach' service. It announces new research findings regarding the company's product, Steriwave, and mentions a poster presentation at a conference. While it contains scientific information, it does not fit into specific financial categories like 10-K, IR, or ER. As it is a general corporate announcement distributed through a regulatory channel (RNS), it falls under the 'Regulatory Filings' (RNS) category.
2023-10-18 English
Steriwave now in Canada's East Coast
Regulatory Filings Classification · 98% confidence The document is a press release distributed via the RNS Reach service, which is a non-regulatory distribution channel for corporate news. It announces the implementation of the company's product, Steriwave, in a specific hospital. Since it is a general corporate announcement regarding business operations and product adoption that does not fit into specific financial reporting categories like 10-K, ER, or others, it falls under the fallback category of Regulatory Filings (RNS).
2023-10-13 English
Ondine to present poster at IP2023, Liverpool
Regulatory Filings Classification · 98% confidence The document is a press release distributed via the London Stock Exchange's 'Reach' service. It announces that Ondine Biomedical Inc. will be presenting research at an upcoming conference (IP2023). It does not contain financial statements, regulatory filings, or specific corporate governance disclosures, but rather serves as a general corporate announcement regarding research activities. As it does not fit into the specific categories like 10-K, ER, or M&A, it falls under the 'Regulatory Filings' (RNS) category as a general corporate announcement.
2023-10-10 English
Hospital to adopt Steriwave as standard-of-care
Regulatory Filings Classification · 98% confidence The document is a press release distributed via the RNS (Regulatory News Service) Reach platform. It announces a commercial update regarding a hospital's adoption of the company's technology (Steriwave). As it is a general corporate announcement that does not fit into specific financial reporting categories like 10-K, IR, or ER, and is not a report publication announcement, it falls under the fallback category for regulatory announcements.
2023-10-09 English
Burnaby Hospital deploys Steriwave
Regulatory Filings Classification · 98% confidence The document is a press release distributed via the London Stock Exchange's 'Reach' service. It announces a specific operational update regarding the deployment of the company's 'Steriwave' technology at Burnaby Hospital. As it is a general corporate announcement regarding business operations rather than a financial report, dividend notice, or governance filing, it falls under the 'Regulatory Filings' (RNS) category as the appropriate fallback for miscellaneous corporate news.
2023-09-29 English

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.